Abstract | BACKGROUND AIMS: METHODS: Our cohort consisted of 113 patients with liver biopsy-confirmed NAFLD and 21 age-matched healthy controls. Serum sCD14 levels were measured by an enzyme-linked immunosorbent assay. RESULTS: Serum sCD14 levels were significantly associated with diagnosis of NASH and the area under the receiver operator characteristic curve (AUROC) to distinguish between not NASH and NASH was 0.802. Moreover, serum sCD14 levels were significantly associated with the disease activity based on NAFLD activity score and hepatic CD14 mRNA expression, which is correlated with membrane CD14 (mCD14) expression, in patients with NAFLD. In multiple regression analysis, the serum sCD14 levels were independently associated with liver inflammation. The AUROC to distinguish between mild and severe liver inflammation in patients with NAFLD was 0.752. CONCLUSIONS:
|
Authors | Yuji Ogawa, Kento Imajo, Masato Yoneda, Takaomi Kessoku, Wataru Tomeno, Yoshiyasu Shinohara, Shingo Kato, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Hiroyuki Kirikoshi, Shin Maeda, Satoru Saito, Koichiro Wada, Atsushi Nakajima |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 6
Pg. e65211
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23762319
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Lipopolysaccharide Receptors
- Lipopolysaccharides
|
Topics |
- Adult
- Animals
- Case-Control Studies
- Cell Line
- Fatty Liver
(blood, pathology)
- Female
- Humans
- Inflammation
(blood, pathology)
- Lipopolysaccharide Receptors
(blood)
- Lipopolysaccharides
(pharmacology)
- Liver
(drug effects, metabolism, pathology)
- Male
- Mice
- Middle Aged
- Non-alcoholic Fatty Liver Disease
- ROC Curve
- Regression Analysis
- Solubility
|